Human Ubiquilin 1 Antibody

Applications

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Preparation and Storage

Background: Ubiquilin 1

Ubiquilin-1 (also known as DA41 and PLIC-1/Protein Linking IAP with Cytoskeleton 1) is a 62-70 kDa intracellular member of the UBL-UBA family of proteins. Consistent with its name, it ubiquitously expressed, and is particularly prominent in skeletal muscle and neurons. Multiple functions have been attributed to ubiquilin-1. For instance, it is now known to be a key player in APP processing. On the cleavage side, ubiquilin-1 binds to PS/presenilin, a component of the gamma -secretase complex that cleaves APP. Ubiquilin-1 appears to target both ubiquitinated single chain PS to the proteosome, and aggregated PS to the aggresome. With respect to APP, ubiquilin-1 serves as a molecular chaperone, binding to and inhibiting APP aggregation. On cells expressing CD47, Ubiquilin-1 acts as an intermediary between integrins, the cytoskeleton and CD47, promoting cell spreading. And in neurons, ubiquilin-1 stabilizes both membrane and GABA subunit stability, enhancing inhibitory synaptic transmission. Human ubiquilin-1 is 589 amino acids (aa) in length. It contains one ubiquitin-like domain (aa 37-111), an S5a binding site (aa 72-105) and a UBA binding region (aa 548-585). There are multiple splice variants, ranging from 19-59 kDa in size. One shows a deletion of aa 418-445, a second contains a three aa substitution for aa 151-589, a third possesses a 29 aa substitution for aa 112-589, and a fourth shows a deletion of aa 61-237 coupled to a second deletion of aa 361‑589. Over aa 546-585, human and mouse ubiquilin-1 are identical in amino acid sequence.

Product Datasheets

Related Research Areas

• DNA Damage and Repair
• Parkinson's Disease Related Molecules